These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 30151852

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy.
    Schless SH, Cenni F, Bar-On L, Hanssen B, Kalkman B, O'brien T, Aertbeliën E, Van Campenhout A, Molenaers G, Desloovere K.
    Dev Med Child Neurol; 2019 Jul; 61(7):783-790. PubMed ID: 30320442
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Botulinum neurotoxin type A responders among children with spastic cerebral palsy: Pattern-specific effects.
    Papageorgiou E, Peeters N, Staut L, Molenaers G, Ortibus E, Van Campenhout A, Desloovere K.
    Eur J Paediatr Neurol; 2024 Mar; 49():131-140. PubMed ID: 38518417
    [Abstract] [Full Text] [Related]

  • 6. Effects of leg muscle botulinum toxin A injections on walking in children with spasticity-related cerebral palsy: a systematic review.
    Ryll U, Bastiaenen C, De Bie R, Staal B.
    Dev Med Child Neurol; 2011 Mar; 53(3):210-6. PubMed ID: 21291464
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
    Lorin K, Forsberg A.
    Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduced Cross-Sectional Muscle Growth Six Months after Botulinum Toxin Type-A Injection in Children with Spastic Cerebral Palsy.
    De Beukelaer N, Weide G, Huyghe E, Vandekerckhove I, Hanssen B, Peeters N, Uytterhoeven J, Deschrevel J, Maes K, Corvelyn M, Costamagna D, Gayan-Ramirez G, Van Campenhout A, Desloovere K.
    Toxins (Basel); 2022 Feb 14; 14(2):. PubMed ID: 35202166
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy.
    Peeters N, Papageorgiou E, Hanssen B, De Beukelaer N, Staut L, Degelaen M, Van den Broeck C, Calders P, Feys H, Van Campenhout A, Desloovere K.
    Toxins (Basel); 2022 Sep 29; 14(10):. PubMed ID: 36287944
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB, Rosales RL, Dressler D.
    J Neural Transm (Vienna); 2009 Mar 29; 116(3):319-31. PubMed ID: 19142573
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
    Lin YC, Lin IL, Chou TF, Lee HM.
    J Neuroeng Rehabil; 2016 Mar 12; 13():25. PubMed ID: 26969526
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
    El O, Peker O, Kosay C, Iyilikci L, Bozan O, Berk H.
    J Child Neurol; 2006 Dec 12; 21(12):1009-12. PubMed ID: 17156689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.